Document ID: 16730

Text:
(r) Intellectual Property. The Company and its Subsidiaries collectively own, possess, license or have other rights to use all material foreign and domestic patents, patent applications, trade and service marks, trade and service mark registrations, trade names, copyrights, licenses, inventions, trade secrets, technology, know-how and other proprietary rights and processes necessary for the conduct of their businesses, taken as a whole, as now conducted or as proposed in the SEC Reports to be conducted (collectively, the Intellectual Property). To the Companys Knowledge, (i) there are no rights of third parties to any Intellectual Property, other than as licensed by the Company; (ii) the Companys or its Subsidiaries use of any such Intellectual Property in the conduct of its business as presently conducted does not infringe upon the rights of any third parties; (ii) there is no infringement by third parties of any such Intellectual Property; (iii) there is no pending or threatened Action challenging the Companys rights in or to or scope of any such Intellectual Property; (iv) there is no pending or threatened Action challenging the validity or scope of any such Intellectual Property; and (v) there is no pending or threatened Action that the Company infringes or otherwise violates any patent, trademark, copyright, trade secret or other proprietary rights of others. The Company is not aware of any facts required to be disclosed to the U.S. Patent and Trademark Office which have not been disclosed to the U.S. Patent and Trademark Office and which would preclude the grant of a patent in connection with any patent application of the Intellectual Property or could form the basis of a finding of invalidity with respect to any issued patents of the Intellectual Property. The Company and its Subsidiaries collectively have taken reasonable security measures to protect the secrecy, confidentiality and value of all of the Intellectual Property, except where the failure to do so would not, individually or in the aggregate, have or reasonably be expected to have a Material Adverse Effect.

Named Entities:

Tokenized Text:
(
r
)
Intellectual
Property
.
The
Company
and
its
Subsidiaries
collectively
own
,
possess
,
license
or
have
other
rights
to
use
all
material
foreign
and
domestic
patents
,
patent
applications
,
trade
and
service
marks
,
trade
and
service
mark
registrations
,
trade
names
,
copyrights
,
licenses
,
inventions
,
trade
secrets
,
technology
,
know-how
and
other
proprietary
rights
and
processes
necessary
for
the
conduct
of
their
businesses
,
taken
as
a
whole
,
as
now
conducted
or
as
proposed
in
the
SEC
Reports
to
be
conducted
(
collectively
,
the
Intellectual
Property
)
.
To
the
Companys
Knowledge
,
(
i
)
there
are
no
rights
of
third
parties
to
any
Intellectual
Property
,
other
than
as
licensed
by
the
Company
;
(
ii
)
the
Companys
or
its
Subsidiaries
use
of
any
such
Intellectual
Property
in
the
conduct
of
its
business
as
presently
conducted
does
not
infringe
upon
the
rights
of
any
third
parties
;
(
ii
)
there
is
no
infringement
by
third
parties
of
any
such
Intellectual
Property
;
(
iii
)
there
is
no
pending
or
threatened
Action
challenging
the
Companys
rights
in
or
to
or
scope
of
any
such
Intellectual
Property
;
(
iv
)
there
is
no
pending
or
threatened
Action
challenging
the
validity
or
scope
of
any
such
Intellectual
Property
;
and
(
v
)
there
is
no
pending
or
threatened
Action
that
the
Company
infringes
or
otherwise
violates
any
patent
,
trademark
,
copyright
,
trade
secret
or
other
proprietary
rights
of
others
.
The
Company
is
not
aware
of
any
facts
required
to
be
disclosed
to
the
U
.
S
.
Patent
and
Trademark
Office
which
have
not
been
disclosed
to
the
U
.
S
.
Patent
and
Trademark
Office
and
which
would
preclude
the
grant
of
a
patent
in
connection
with
any
patent
application
of
the
Intellectual
Property
or
could
form
the
basis
of
a
finding
of
invalidity
with
respect
to
any
issued
patents
of
the
Intellectual
Property
.
The
Company
and
its
Subsidiaries
collectively
have
taken
reasonable
security
measures
to
protect
the
secrecy
,
confidentiality
and
value
of
all
of
the
Intellectual
Property
,
except
where
the
failure
to
do
so
would
not
,
individually
or
in
the
aggregate
,
have
or
reasonably
be
expected
to
have
a
Material
Adverse
Effect
.